Baolingbao Biology Co Ltd (002286) - Total Liabilities
Based on the latest financial reports, Baolingbao Biology Co Ltd (002286) has total liabilities worth CN¥625.57 Million CNY (≈ $91.54 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Baolingbao Biology Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Baolingbao Biology Co Ltd - Total Liabilities Trend (2006–2025)
This chart illustrates how Baolingbao Biology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Baolingbao Biology Co Ltd.
Baolingbao Biology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Baolingbao Biology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
mF International Limited Ordinary Shares
NASDAQ:MFI
|
USA | $21.51 Million |
|
OPUS GLOBAL Nyrt
BUD:OPUS
|
Hungary | Ft625.22 Billion |
|
Logan Energy Corp
V:LGN
|
Canada | CA$73.27 Million |
|
29METALS Ltd
AU:29M
|
Australia | AU$595.63 Million |
|
LAY-OUT Planning Consultants Co. Ltd.
SHE:300989
|
China | CN¥244.19 Million |
|
Hefei Taihe Optoelectronic
SHG:603656
|
China | CN¥791.75 Million |
|
YungShin Global Holding Corp
TW:3705
|
Taiwan | NT$4.59 Billion |
|
Jiangsu Huifeng Agrochemical Co Ltd
SHE:002496
|
China | CN¥987.73 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Baolingbao Biology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Baolingbao Biology Co Ltd to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Baolingbao Biology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Baolingbao Biology Co Ltd (2006–2025)
The table below shows the annual total liabilities of Baolingbao Biology Co Ltd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥547.81 Million ≈ $80.16 Million |
-13.38% |
| 2024-12-31 | CN¥632.44 Million ≈ $92.55 Million |
-6.36% |
| 2023-12-31 | CN¥675.41 Million ≈ $98.83 Million |
-32.58% |
| 2022-12-31 | CN¥1.00 Billion ≈ $146.59 Million |
-17.60% |
| 2021-12-31 | CN¥1.22 Billion ≈ $177.90 Million |
+19.62% |
| 2020-12-31 | CN¥1.02 Billion ≈ $148.73 Million |
+6.79% |
| 2019-12-31 | CN¥951.76 Million ≈ $139.27 Million |
-8.24% |
| 2018-12-31 | CN¥1.04 Billion ≈ $151.79 Million |
+78.29% |
| 2017-12-31 | CN¥581.79 Million ≈ $85.13 Million |
+37.40% |
| 2016-12-31 | CN¥423.43 Million ≈ $61.96 Million |
-2.76% |
| 2015-12-31 | CN¥435.44 Million ≈ $63.72 Million |
+37.49% |
| 2014-12-31 | CN¥316.69 Million ≈ $46.34 Million |
+31.48% |
| 2013-12-31 | CN¥240.88 Million ≈ $35.25 Million |
-18.43% |
| 2012-12-31 | CN¥295.31 Million ≈ $43.21 Million |
-16.12% |
| 2011-12-31 | CN¥352.06 Million ≈ $51.52 Million |
+6.86% |
| 2010-12-31 | CN¥329.46 Million ≈ $48.21 Million |
-21.84% |
| 2009-12-31 | CN¥421.50 Million ≈ $61.68 Million |
-16.68% |
| 2008-12-31 | CN¥505.85 Million ≈ $74.02 Million |
+23.80% |
| 2007-12-31 | CN¥408.62 Million ≈ $59.79 Million |
+3.34% |
| 2006-12-31 | CN¥395.40 Million ≈ $57.86 Million |
-- |
About Baolingbao Biology Co Ltd
Baolingbao Biology Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of functional sugar in China and internationally. The company offers prebiotics, including galacto-oligosaccharides, isomaltooligosaccharides, fructooligosaccharides, and xylooligosaccharides; sugar alcohols and sources, such as erythritol, trehalose, crystallized fructose, a… Read more